Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Travere Therapeutics stock have an average target of 33.08, with a low estimate of 20 and a high estimate of 45. The average target predicts an increase of 99.76% from the current stock price of 16.56.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$33.08	$35	$45
Change	+20.77%	+99.76%	+111.35%	+171.74%

Analyst Ratings

The average analyst rating for Travere Therapeutics stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	4	4	4	4	4	5
Buy	6	6	6	8	8	7
Hold	3	3	2	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	12	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Apr 3, 2025
Greg Harrison B of A Securities	B of A Securities	Strong Buy Maintains $29 → $31	Strong Buy	Maintains	$29 → $31	+87.20%	Apr 1, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $42 → $44	Buy	Maintains	$42 → $44	+165.70%	Feb 26, 2025
Carly Kenselaar Citigroup	Citigroup	Strong Buy Maintains $31 → $35	Strong Buy	Maintains	$31 → $35	+111.35%	Feb 24, 2025
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Feb 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

399.63M

Increased by 71.39%

from 233.18M

Revenue Next Year

620.39M

Increased by 55.24%

from 399.63M

EPS This Year

-1.45

from -4.08

EPS Next Year

1.02

from -1.45

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	198.32M	131.84M	109.46M	145.24M	233.18M	399.63M	620.39M	735.96M
Revenue Growth	13.11%	-33.52%	-16.97%	32.69%	60.55%	71.39%	55.24%	18.63%
EPS	-3.56	-3.01	-4.37	-1.50	-4.08	-1.45	1.02	1.58
EPS Growth	-	-	-	-	-	-	-	55.14%
Forward PE	-	-	-	-	-	-	16.28	10.49
No. Analysts	-	-	-	-	-	17	16	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	467.7M	831.1M	937.7M
Avg	399.6M	620.4M	736.0M
Low	324.5M	433.7M	575.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	100.6%	108.0%	51.1%
Avg	71.4%	55.2%	18.6%
Low	39.2%	8.5%	-7.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.59	3.13	3.39
Avg	-1.45	1.02	1.58
Low	-2.39	-0.96	0.31

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	233.3%
Avg	-	-	55.1%
Low	-	-	-69.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.